Clinical Trials

Navigantis achieved the first successful neurovascular clinical cases performed using its VASCO interventional robotic platform for patients with neurovascular disorders. The VASCO interventional robotic platform...

SamanTree Medical has revealed that its Histolog scanner, a confocal laser microscope, significantly decreased breast-conserving surgery (BCS) reoperation rates by 67% as observed in...

US-based Protaryx Medical has completed a first-in-human trial of its transseptal puncture (TSP) device. The company’s trial enrolled five patients, with the TSP procedure carried...

EndoQuest Robotics announced it received FDA investigational device exemption (IDE) for a study of its surgical robot. The IDE allows the Houston, Texas-based company...

ShiraTronics announced it initiated its FDA investigational device exemption (IDE) pivotal trial for its neuromodulation therapy. The RELIEV-CM2 clinical study evaluates the company’s neuromodulation...

Nervonik announced it completed the first-in-human clinical study of its peripheral nerve stimulation (PNS) device. The Los Angeles-based startup designed its proprietary device to enhance...

The regulatory study validated Remplir as a safe and effective biological medical device for use in the surgical repair of peripheral nerves and will...

BrioHealth Solutions enroled its first patients in the U.S. for the INNOVATE trial of its BrioVAD system. Burlington, Massachusetts–based BrioHealth has had its BrioVAD...

EmStop has completed the ‘Controlled Arterial Protection to Ultimately Remove Embolic Material’ (CAPTURE-1) early feasibility clinical study which assessed the EmStop embolic protection system. The...